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Abnormalities in motor activity represent a central feature in major depressive disorder.
However, measurement issues are poorly understood, limiting the use of objective mea-
surement of motor activity for diagnostics and treatment monitoring.
Methods
To improve measurement issues, especially sensor placement, analytic strategies and diur-
nal effects, we assessed motor activity in depressed patients at the beginning (MD; n=27)
and after anti-depressive treatment (MD-post; n=18) as well as in healthy controls (HC;
n=16) using wrist- and chest-worn accelerometers. We performed multiple analyses regard-
ing sensor placements, extracted features, diurnal variation, motion patterns and posture to
clarify which parameters are most powerful in distinguishing patients from controls and
monitoring treatment effects.
Results
Whereas most feature-placement combinations revealed significant differences between
groups, acceleration (wrist) distinguished MD from HC (d=1.39) best. Frequency (vertical
axis chest) additionally differentiated groups in a logistic regression model (R2=0.54).
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Accordingly, both amplitude (d=1.16) and frequency (d=1.04) showed alterations, indicat-
ing reduced and decelerated motor activity. Differences between MD and HC in gestures
(d=0.97) and walking (d=1.53) were found by data analysis from the wrist sensor.
Comparison of motor activity at the beginning and after MD-treatment largely confirms
our findings.
Limitations
Sample size was small, but sufficient for the given effect sizes. Comparison of depressed
in-patients with non-hospitalized controls might have limited motor activity differences
between groups.
Conclusions
Measurement of wrist-acceleration can be recommended as a basic technique to capture
motor activity in depressed patients as it records whole body movement and gestures. De-
tailed analyses showed differences in amplitude and frequency denoting that depressed pa-
tients walked less and slower.
Introduction
Abnormalities in motor activity do not only reflect the classification criterion of psychomotor
retardation in major depressive disorder (MDD), but are also related to other criteria like di-
minished interest in daily life activities [1,2]. Accordingly, reduced motor activity has been
shown in patients with current MDD [3–6] and treatment response was related to increased
motor activity [5,7–10].
Fortunately, the use of objective measurement of motor activity has increased in recent
years. Technological progress has led to miniaturised accelerative devices which can assess
motor activity with high reliability and validity [11,12]. In contrast, meta-analyses revealed
only marginal validity of recall questionnaires [13]. In line with this, recent long-term tele-
health approaches already use objectively monitored motor activity as a proxy for depressive
symptomatology [14–16].
In a recent quantitative review, Burton et al. [17] summarised existing studies using actigra-
phy to objectively measure motor activity in depressed patients. The review included 19 papers
with 16 studies with a total of 412 mostly female patients of various ages. 11 papers dealt with
case-control studies and 10 papers referred to longitudinal studies. Participants were diagnosed
with MDD (8 papers), depression in association with bipolar disorder (8 papers) or Seasonal
Affective Disorder (3 papers). Total assessment period ranged between 2 and 30 days with day-
time (15 papers) as well as sleep actigraphy data (14 papers) [17]. Overall, Burton et al. [17]
reported less daytime activity in patients with depression compared to healthy controls. Fur-
thermore, treatment studies in depression showed moderate increases in daytime activity over
the course of treatment as well as a reduction of night-time activity.
Most importantly, Burton et al. [17] highlighted three methodological limitations of existing
studies, which need to be addressed to increase the usefulness of assessing motor activity. First,
there is no research and no recommendations regarding the placement of the sensor. Nearly all
studies covered in the review used actigraphy devices which were attached to patients’ wrist.
Only one study used accelerometers attached to the chest. This is surprising as attaching the
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device to the centre of mass, the chest or the waist, is the recommendation in the area of motor
activity and exercise [18]. Currently, the effect of sensor placement is largely unknown. Thus,
having information about different actigraphy devices and protocols is demanded [17,19] to
ensure the best method for collecting activity data in depressed subjects. In addition, utilisation
of only one single sensor at the wrist limits qualitative analyses of motor activity. For example,
motor activity measured at the wrist can result from gestures or from arm swings while walking
[20]. Thus, more information is necessary to understand the abnormalities in motor activity in
patients with depression.
Second, Burton et al. [17], among others [21–23], call for an improvement of analytic meth-
ods in order to ensure that all relevant features are utilised when categorising behaviour types.
For instance, movement patterns like sitting, standing and lying are features which can be ex-
tracted from an acceleration signal quite easily. Yet, most of the studies reported solely cap-
tured or calculated global motor activity counts from acceleration data, thereby not taking a
deeper look at the actual behaviour. Further, motor activity is generally characterised by ampli-
tude and frequency. Thus, clarifying if patients walk less (amplitude) or slower (frequency)
than healthy controls requires up to date analytic methods.
Third, Burton et al. [17] request standardised methods to detect diurnal variation, thereby
figuring out the most suitable timeframe to distinguish abnormalities in motor activity of pa-
tients suffering fromMDD compared to healthy controls, for example. Similarly, no recom-
mendations are available to date.
To overcome the methodological limitations voiced by Burton et al. [17], we monitored
motor activity using the non-dominant wrist as in most previous studies [17] and additionally
at the centre of mass (chest) for 24 hours. Subjects were in-patients suffering fromMDD,
which were assessed at the beginning (MD) and after four weeks of inpatient treatment (MD-
post), as well as healthy controls (HC). We used sophisticated methods to analyse the activity
data and did take diurnal variation into account.
In order to replicate findings from Burton et al.’s [17] systematic review, we hypothesised
lower motor activity measured at the wrist in MD compared to HC (hypothesis I). To clarify
the best sensor placement, analytic strategy and diurnal timeframe to detect differences be-
tween MD and HC, we performed multiple explorative analysis differentiating MD and HC re-
garding: a) sensor placements (wrist- vs. chest-accelerometry) and extracted features (pure
acceleration vs. amplitude and frequency extracted using spectral analysis) as well as b) diurnal
variation of motor activity, motion patterns (sitting/standing vs. lying and walking) and pos-
ture (chest inclination).
Again, to replicate findings from Burton et al.’s [17] systematic review, we hypothesised in-
creased motor activity assessed at the wrist in MD-post compared to MD-pre (hypothesis II).
To clarify the most adequate sensor placement, analytic strategy and diurnal timeframe to de-
tect differences between MD-pre and MD-post, we performed multiple explorative analysis in-
vestigating: a) sensor placements and extracted features as well as b) diurnal variation of motor
activity, motion patterns and posture.
Methods
Design
The study was conceptualised both as a case-control and pre-post treatment design. Motor ac-
tivity of patients suffering fromMDD was assessed at the beginning (MD) and after 4 weeks of
hospitalisation (MD-post); a comparison group of healthy controls (HC) was assessed once.
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Study participants
The sample consisted of 27 in-patients (MD: 12 female, 15 male) suffering fromMDD and a
comparison group of 16 healthy adults (HC: 6 female, 10 male). The difference in the sex ratio
and the mean age of the two groups were not significantly different with 39.6 years for MD
(range = 19–64, SD = 12.4) and 41.3 years for HC (range = 21–62, SD = 12.3). Moreover, there
was no significant difference in the BMI [kg/m2] of MD (M = 25.7, range = 16.5–38.2,
SD = 5.5) and HC (M = 27.2, range = 19.5–36.4, SD = 5.3).
Motor activity data from all patients were available at the beginning of in-patient treatment,
whereas after 4-weeks of in-patient treatment only 18 out of the 27 patients were measured.
Drop-out analyses revealed no significant differences between patients remaining in the study
and drop-outs regarding age, gender, BMI, HDRS-Score and mean motor activity. In order to
compare motor activity of untreated patients with HC, MD (n = 27) vs. HC (n = 16) were
taken into account. In order to analyse treatment effects only patients participating at both as-
sessments were included (n = 18).
Patients. Patients were recruited within the study SOLID (“Stress, Obesity, Liverfat, Insu-
lin Resistance in Depression”, German Clinical Trials Register—ID: DRKS00004324, http://
drks-neu.uniklinik-freiburg.de/drks_web/navigate.do?navigationId = trial.HTML&TRIAL_
ID=DRKS00004324) at the Clinic for Psychiatry and Psychotherapy of the Central Institute of
Mental Health (ZI) in Mannheim.
Patients attending the clinic with unipolar disorder or bipolar disorder were included
in the study if they were in a moderate to severely depressive state and between 18 and 65
years of age. However, even though bipolar disorder was not an exclusion criterion in
the SOLID study, we only assessed motor activity in patients with unipolar depression.
Diagnoses were given following clinical psychiatric examination and chart review. Severity of
depression was assessed by the treating psychiatrists according to the 21-item Hamilton
Depression Rating Scale (HDRS)—at least 18 points right after admission were mandatory to
be included in the study. Psychiatrists carried out all the HDRS-ratings at pre-assessment
(MD) and at post assessment (MD-post). There was a significant difference [t(17) = 11.48,
p<0.001] in the HDRS-Scores between MD-pre (M = 23.6, SD = 4.6) and MD-post (M = 11.4,
SD = 5.9).
Exclusion criteria were a current psychotic episode, a depressive episode of organic nature,
dementia, current use of steroids, alcohol or sedative dependency, or surgery in the last six
months. Patients with a significant risk of suicidal behaviour were excluded, especially when
they had active suicidal ideations with some intent to act. Patients with non-specific active sui-
cidal thoughts were not excluded. In addition, patients of consent or legal incapacity and pa-
tients suffering from anaemia were also excluded.
Patients obtaining psychotropic drugs prior to their hospitalisation received a five-day wash
out period without pharmacological treatment carried out prior to our study [24]. At the time
of second measurement, they received various types, combinations and doses of psychophar-
macological treatment.
Controls. A control group of healthy individuals comparable to the patient group regard-
ing gender, age and body-mass-index was recruited via a telephone list of interested study par-
ticipants. Participants with a current mental disorder, prior psychiatric disorders or illness
influencing motor activity were excluded. Furthermore, participants pursuing a job with high
motor activity demands (e.g. construction worker) were also excluded. Thus, the control group
comprised participants performing an office job (e.g. chemist, architect, research assistant),
studying (e.g. pupil, university student) or staying at home (e.g. house-wife, pensioner) at the
time of the assessment. They did not work shifts or suffer from sleep deprivation. To determine
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mental disorders, the control group underwent the Mini International Neuropsychiatric Inter-
view (M.I.N.I., Version 5.0.0) for DSM-IV and ICD-10 [25].
Assessment of motor activity
Each participant carried a portable physiological recorder-analyser system, the Varioport-B
(Becker Engineering, Karlsruhe, Germany). The device with a size of 120x65x22mm and a
weight of 170g enables the attachment of different sensors (e.g. Accelerometers, ECG, EMG,
EDA, etc.) with a maximum of 34 recording channels. The data is stored on a 4GB SD-Card.
Standard rechargeable batteries enable a maximum operation period of 100 hours (for details
see [26,27]). Motor activity was sampled at 32 Hz over a minimum period of 24 hours by 2 ac-
celerative sensors placed on the chest (3-dimensional accelerometry) and on the non-dominant
wrist (1-dimensional accelerometry). Patients’motor activity was assessed for 24 hours at the
beginning of inpatient treatment and—in patients obtaining psychotropic drugs prior to their
hospitalisation—after a 5-day wash-out period. In addition, motor activity of patients was mea-
sured in infirmary for 24 hours after four weeks of pharmacological anti-depressive treatment.
The HC group wore the device for 24 hours in everyday life.
After the application of the portable physiological recorder system by a supervisor, each par-
ticipant was asked to adopt several motion patterns (seated, standing, lying on the back, lying
on the left side, lying on the right side and walking) for approximately 35 seconds according to
the standard protocol of the Freiburger Monitoring System [28]. The participants were in-
structed to carry on with their usual activities (habitual behaviour) during the observation peri-
od. In addition, they were asked to note particular physical activities and sport activities in
a protocol.
Data analysis
All data analyses were computed separately for both accelerometers attached to the wrist and
the chest and for each sensor axis (one axis of the wrist accelerometer and three axes of the
chest accelerometer: vertical, horizontal and sagittal).
First, motor activity was separated offline into AC and DC components by a FIR digital filter
with a cut-off frequency at 0.5 Hz. Raw signal, DC values, and rectified AC values were aver-
aged across data points for each condition and monitoring segment. In addition, the vector (cu-
mulative acceleration) of the three axes of the chest sensor was computed following the rules of
vector addition. All online and offline analyses and artefact checks were performed by the in-
teractive software package “Freiburg Monitoring System” [28] according to a published proce-
dure [29].
Second, mean daily motor activity (acceleration values measured in milli-g) over the 24 h
period as well as the hourly means of motor activity were calculated using SPSS version 21.
Third, raw activity data was segmented into 60-s periods and subjected to Fourier-based spec-
tral analysis using Vision Analyser version 1.04 software (Brain Products, Gilching, Germany,
http://www.brainproducts.com). For further statistical analysis, the mean amplitude (see Figs
1a and 2a) and the centroid frequency (dividing the area of the spectrum into two equal parts;
see Figs 1b and 2b) were computed within the frequency bands from 1 to 3 Hz. The frequency
range 1–3 Hz was used as it covers the main motor activity within our groups (see Figs 1 and 3)
and enabled us to focus gross motor activity, like walking and running. The amplitude of the
spectral analysis is an arbitrary unit (au): the values are based on g but attenuated due to the
computation of the spectrum and the nonstationarity of the data.
Fourth, the standard protocol data was used to calculate individual milli-g-cut-off-values
and thereby to identify the duration of participant’s motion patterns (in hours) divided into
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the situations sitting/standing, lying and walking within the 24 h periods; these analyses were
conducted following the principle of a published procedure [28]. Fifth, mean daily motor activ-
ity (AC values measured in milli-g) over the 24 h were computed for the situations sitting/
standing, lying and walking.
Statistical analysis
To investigate group differences, t-tests and effect sizes (Cohen’s d) were used after data were
tested for normality. Logistic regression analyses were used to predict the affiliation of partici-
pants to the group of subjects (MD vs. HC) and thereby to identify the best feature-placement
combination. We used the forward method including only the most influential predictors. The
reported measure Nagelkerges R² adjusts Cox and Snell R² to enable a maximum value of 1.
Cox and Snell R² is based on log likelihoods taking sample size into account. Thus, Nagelkerges
R² is the most analogous measure to R² in linear Regression, provided in SPSS [30]. Two-facto-
rial ANOVAs were used to calculate group (MD vs. HC; MD-pre vs. MD-post) and time (24
hours) effects in diurnal variation; post-hoc analyses were conducted using the Newman-Keuls
test. SPSS version 21 was used for all analysis; p-values below 0.05 were considered significant.
Fig 1. Spectral analysis of acceleration (frequency and amplitude) of MD patients at the beginning of treatment (MD) and healthy controls (HC)
captured with the vertical axes of the chest-accelerometer.Mean amplitude values (in au1; grey and black horizontal resp.) as well as the group centroid
frequency (in Hz; grey and black vertical line resp.) for the whole spectrum of walking (1–3Hz) are depicted in Fig 1a, 1b, respectively. 1arbitrary unit: values
are based on g but attenuated due to the computation of the spectrum and the nonstationarity of the data.
doi:10.1371/journal.pone.0124231.g001
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Ethical consideration
The study was approved by the medical ethics committee II of the Medical Faculty Mannheim
at the Ruprecht-Karls-University in Heidelberg. It fulfilled the ethical guidelines for medical
research according to the declaration of Helsinki. Written and oral information about study
procedures were presented to all eligible participants before written informed consent was ob-
tained. Experienced psychiatrists excluded patients with insufficient capacity to provide in-
formed consent from the study. There was no surrogate consent procedure. All participants
were free to withdraw from the study at any time. The participants of the HC group were paid
for participating in the study.
Results
Motor activity in patients at the beginning of treatment (MD) versus
Healthy Controls (HC)
Analyses revealed a significant difference of motor activity assessed at the wrist (see Table 1: ac-
celeration wrist) between MD and HC (p = 0.001), in which MD (30.35 milli-g) showed 26%
lower motor activity than HC (41.22 milli-g). Having received comparable findings to previous
studies [17], we were able to apply meaningful analyses on details of motor activity, like sensor
placement, features and diurnal variation.
Fig 2. Diurnal variation of motor activity measured at the wrist a) in MD patients at the beginning of
treatment (MD) and healthy controls (HC) as well as b) in MD patients at the beginning (MD-pre) and
after 4 weeks of inpatient treatment (MD-post). * show significant differences in hours analysed with post-
hoc test (Newman-Keuls).
doi:10.1371/journal.pone.0124231.g002
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Sensor placement and extracted features
To identify the most powerful parameter for distinguishing motor activity between MD and
HC, we extracted different features, like mean acceleration, amplitude and centroid frequency
from spectral analysis, and motion patterns across different placements (wrist vs. chest). As
stated above, mean acceleration is the mean intensity of the acceleration signal over time, rep-
resenting mean motor activity. Amplitude and centroid frequency [Hz] are features extracted
using spectral analysis.
As shown in Fig 1, spectral analyses deconstruct the signal into amplitude (y-axis) and
frequency (x-axis). Descriptively, Fig 1 depicts the vertical sensor axis (chest) showing higher
amplitudes (y-axis) in HC (grey line) across the entire frequency spectrum (x-axis). As repre-
sented in Fig 1a, mean amplitude was heightened in HC compared to MD (grey and black hori-
zontal lines respectively). Analysis was limited to the range of 1 to 3 Hz, which represented the
spectrum of slow walking to running. Fig 1b represents higher frequencies (x-axis) in HC com-
pared to MD, illustrated in the curve shifted to the right. This can be quantified by calculating
the centroid frequency [Hz], which divides the frequency spectrum into two equal parts. De-
scriptively, the centroid frequency (grey vs. black vertical lines) was heightened in HC com-
pared to MD. In practice, this means that HC showed higher amplitudes (Fig 1a) as well as
higher frequencies (Fig 1b) than MD—suggesting they might walk more and faster.
Fig 3. Spectral analysis of acceleration (frequency and amplitude) of MD patients at the beginning (MD-pre) and after 4 weeks (MD-post) of
inpatient treatment captured with the vertical axes of the chest-accelerometer.Mean amplitude values (milli-g; grey and black horizontal lines resp.) as
well as the group centroid frequency (in Hz; grey and black vertical lines resp.) for the whole spectrum of walking (1–3Hz) are depicted in Fig 3a, 3b,
respectively. 1arbitrary unit: values are based on g but attenuated due to the computation of the spectrum and the nonstationarity of the data.
doi:10.1371/journal.pone.0124231.g003
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Table 1 shows the statistics of comparing groups regarding multiple extracted features
across placements (feature-placement combinations). Feature-placement combinations are
sorted by their power to differentiate groups (effect size). Out of the 16 calculated feature-
placement combinations, 13 revealed a significant difference between MD and HC, showing
higher motor activity in HC (even with Bonferroni adjustment, 12 achieved a significant p
value). The acceleration of the wrist did show the highest effect size in distinguishing both
groups (d = 1.39). In addition, the mean amplitude of the wrist (d = 1.22) as well as that of the
chest sensor (vertical axis) showed high effect sizes (d = 1.16). The vertical axis of the chest sen-
sor showed the highest effect size regarding frequency differences (d = 1.04).
The inference statistics confirmed our descriptive findings from Fig 1a and 1b, revealing sig-
nificant heightened amplitude [t(41) = -3.72, p = 0.001] and centroid frequency [t(41) = -2.94,
p =<0.005] in HC compared to MD (see Table 1: amplitude chest vertical and centroid fre-
quency vertical). In numbers, motor activity of HC compared to MD was quantitatively (am-
plitude) enhanced by 25% (1.64 milli-g/2.18 milli-g; d = 1.16). Furthermore, we detected
qualitative (centroid frequency) heightened motor activity in HC (d = 1.04). Looking at the
motion patterns, analysis revealed that HC spent on average 1.47 (8.62 vs. 10.09) hours less
Table 1. Differences in meanmotor activity andmotion patterns over a 24 hour period among MD patients in the beginning of treatment (MD) and
healthy controls (HC)—itemised in several feature-placement combinationsmeasured in different accelerometer axes and sorted according to ef-
fect sizes by Cohen.
feature-placement combinations MD (SD) HC (SD) t df p d
acceleration wrist [milli-g] 30.35 (7.74) 41.22 (7.92) -4.42 41 0.001*** 1.39
amplitude1 wrist [au2] 1.64 (0.48) 2.18 (0.41) -3.78 41 0.001*** 1.22
amplitude1 chest vertical [au2] 0.72 (0.18) 0.93 (0.19) -3.72 41 0.001*** 1.16
amplitude1 chest horizontal [au2] 0.61 (0.13) 0.79 (0.18) -3.69 41 0.001*** 1.12
acceleration chest (vector)3 [milli-g] 49.87 (10.20) 61.19 (10.92) -3.43 41 0.001*** 1.07
centroid frequency1 chest vertical [Hz] 1.85 (0.07) 1.92 (0.07) -3.31 41 0.002** 1.04
acceleration chest horizontal [milli-g] 17.31 (3.42) 20.95 (3.64) -3.64 41 0.002** 1.03
acceleration chest sagittal [milli-g] 19.53 (3.46) 23.03 (3.63) -3.15 41 0.003** 0.99
acceleration chest vertical [milli-g] 16.77 (4.33) 20.91 (4.69) -2.94 41 0.005** 0.92
amplitude1 chest sagittal [au2] 0.66 (0.13) 0.78 (0.14) -2.84 41 0.007** 0.89
centroid frequency1 chest sagittal [Hz] 1.77 (0.05) 1.81 (0.05) -2.51 41 0.016* 0.79
time spent reclined [hours] 10.09 (1.99) 8.62 (2.11) 2.29 41 0.027* 0.72
time spent walking [hours] 3.53 (1.36) 4.37 (1.26) -2.02 41 0.050* 0.64
centroid frequency1 wrist [Hz] 1.82 (0.03) 1.83 (0.03) -1.41 41 0.166, n.s. 0.45
centroid frequency1 chest horizontal [Hz] 1.99 (0.06) 1.97 (0.05) 1.18 41 0.246, n.s. 0.38
time spent sitting/standing [hours] 10.39 (1.79) 11.01 (2.26) -0.99 41 0.327, n.s. 0.30
acceleration wrist during walking [milli-g] 98.66 (14.74) 120.58 (13.95) -4.81 41 0.000, n.s. 1.53
acceleration wrist during sitting/standing & lying [milli-g] 18.62 (5.24) 23.54 (4.91) -3.05 41 0.004, n.s. 0.97




d: Cohen’s effect size.
1calculated with spectral analysis;
2arbitrary unit: values are based on g but attenuated due to the computation of the spectrum and the nonstationarity of the data;
3cumulative acceleration of the three axes of the chest sensor computed following the rules of vector addition.
doi:10.1371/journal.pone.0124231.t001
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time per day lying than MD (p<0.05, d = 0.72). Furthermore, HC walked on average 0.84 (4.37
vs. 3.53) hours more per day than MD (p = 0.05, d = 0.64).
In addition, we used multiple logistic regressions to investigate whether and which feature-
placement combination did show an additional contribution when differentiating between
groups (see Table 2). In a first step, we added all acceleration-features to our most prominent
feature “acceleration wrist”, but none of the additional acceleration-features were significant
(Nagelkerkes R2 = 0.42). In a second step, we added all amplitude-features in the range of 1–3
Hz to our most prominent feature “acceleration wrist”, but none of the additional amplitude-
features were significant (Nagelkerkes R2 = 0.42). In a third step, we added all centroid-features
calculated in the range of 1–3Hz to our most prominent feature “acceleration wrist”; here only
the centroid frequency of the chest (vertical axis) revealed significance and improved the model
(descriptively best model Nagelkerkes R2 = 0.54 with the highest prediction accuracy of 79.1%).
Diurnal variation, motion patterns and posture. Fig 2a shows the diurnal variation of
acceleration (wrist) in MD and HC. Descriptively, motor activity was lower in MD during day-
time, but comparable to HC at night. A two-factorial ANOVA showed a significant interaction
[F(23,94) = 2.64, p<0.001] between time and group. We also found significant group [F(1,41)
= 19.1, p<0.001] and time [F(23,94) = 39.36, p<0.001] effects. Post-hoc-tests (Newman-Keuls)
showed significant differences in the hours 9, 10 and 11 (as shown in Fig 2a).
To examine whether differences in activity between MD and HC measured at the wrist re-
sulted from gesture or from arm swing during walking, we calculated the mean acceleration
values measured at the wrist during walking as well as those measured during sitting/standing
and lying. The data captured during walking revealed an effect size about one third higher
compared to the acceleration values measured while HC and MD were not walking (d = 1.53
vs. 0.97; see Table 1).
In addition, in explorative analysis HC showed a more upright posture compared to MD
during sitting and standing (assessed with the vertical axis of the chest sensor). Although Stu-
dent’s t-Test showed no significant difference [t(41) = 1.52, p = 0.136], we found a medium ef-
fect size (d = 0.50) suggesting that MD leaned forward more in comparison to HC (9 degrees
difference in the vertical body axis) within the motion patterns sitting and standing.
Motor activity in MDD: pre (MD-pre) versus post (MD-post) treatment
Motor activity assessed at the wrist differed significantly (p>0.05) among MD-pre (30.49
milli-g) and MD-post (37.04 milli-g), with 18% higher motor activity in MD-post (see Table 3:
Table 2. Logistic regression analysis to predict the affiliation of participants to the group of subjects (MD patients at the beginning of treatment
(MD) vs. healthy controls (HC)) combining several calculated feature-placement combinations; significant combinations (*) are highlighted in
bold characters.
feature-placement combinations Nagelkerkes R2 prediction
accuracy [%]
acceleration wrist [milli-g]* + acceleration chest (vector)1 [milli-g] + acceleration chest vertical [milli-g]
+ acceleration chest sagittal [milli-g] + acceleration chest horizontal [milli-g]
0.424 76.7
acceleration wrist [milli-g]* + amplitude2 wrist [au3] + amplitude2 chest vertical [au3] + amplitude2 chest
sagittal [au3] + amplitude2 chest horizontal [au3]
0.424 76.7
acceleration wrist [milli-g]* + centroid frequency2 wrist [Hz] + centroid frequency2 chest vertical [Hz]*
+ centroid frequency2 chest sagittal [Hz] + centroid frequency2 chest horizontal [Hz]
0.540 79.1
1cumulative acceleration of the three axes of the chest sensor computed following the rules of vector addition;
2calculated with spectral analysis;
3arbitrary unit: values are based on g but attenuated due to the computation of the spectrum and the nonstationarity of the data.
doi:10.1371/journal.pone.0124231.t002
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acceleration wrist). This result is in line with previous research [17]. Additionally, standard de-
viation of motor activity in MD-post was increased (see Table 3: acceleration wrist). Indeed,
only 12 out of 18 MD-pre patients showed heightened motor activity (acceleration wrist) after
the treatment (MD-post), reflecting 67% of the sample.
Sensor placement and extracted features. As shown in Fig 3, MD-post reached higher
amplitudes (y-axis) across the whole frequency spectrum (x-axis) compared to MD-pre. In the
range of 1 to 3 Hz, statistics confirmed our descriptive finding, showing significant differences
[t(17) = -2.25, p<0.05] with 21% (16.33 milli-g/20.75 milli-g) elevated motor activity in MD-
post (see Table 3: amplitude chest vertical). However, differences in the centroid frequency
(vertical sensor chest) lacked statistical significance (p = 0.11) and revealed only a small effect
size (d = 0.40).
In Table 3, statistics distinguishing motor activity of MD-pre and MD-post by using differ-
ent feature-placement combinations are provided. Feature-placement combinations are sorted
by their power to differentiate MD-pre vs. MD-post (effect size). 10 out of 16 calculated
feature-placement combinations (including the mean acceleration measured at the wrist) re-
vealed significant differences, showing higher motor activity in MD-post compared to MD-
pre. In contrast to the comparison of motor activity between MD and HC (see Table 1), we de-
termined only mean effect sizes illustrating the magnitude of differences in motor activity of
MD-pre compared to MD-post (see Table 3: e.g. acceleration chest horizontal (d = 0.63)).
Diurnal variation, motion patterns and posture. Fig 2b shows differences in the diurnal
variation of motor activity captured at the wrist comparing MD-pre and MD-post.
Table 3. Differences in meanmotor activity andmotion patterns over a 24 hour period among MD patients in the beginning (MD-pre) and after 4
weeks (MD-post) of in-patient treatment—itemised in several feature-placement combinationsmeasured in different accelerometer axes and
sorted according to effect sizes by Cohen.
feature-placement combinations MD-pre (SD) MD-post (SD) t df p d
acceleration chest horizontal [milli-g] 16.93 (3.54) 20.78 (5.68) -2.68 17 0.02* 0.63
amplitude1 chest horizontal [au2] 0.60 (0.15) 0.74 (0.22) -2.60 17 0.02* 0.61
centroid frequency1 wrist [Hz] 1.83 (0.03) 1.85 (0.03) -2.58 17 0.02* 0.61
acceleration wrist [milli-g] 30.49 (8.82) 37.04 (10.11) -2.33 17 0.03* 0.55
acceleration chest vertical [milli-g] 16.33 (4.09) 20.75 (7.42) -2.32 17 0.03* 0.55
acceleration chest (vector)3 [milli-g] 48.71 (11.03) 58.13 (15.93) -2.30 17 0.03* 0.54
acceleration chest sagittal [milli-g] 19.16 (3.79) 22.38 (5.51) -2.28 17 0.04* 0.54
amplitude1 chest vertical [au2] 0.69 (0.18) 0.86 (0.32) -2.25 17 0.04* 0.53
amplitude1 chest sagittal [au2] 0.64 (0.15) 0.75 (0.20) -2.12 17 0.05* 0.50
amplitude1 wrist [au2] 1.67 (0.54) 1.99 (0.61) -2.07 17 0.05* 0.49
centroid frequency1 chest sagittal [Hz] 1.79 (0.05) 1.81 (0.06) -2.02 17 0.06, n.s. 0.48
time spent reclined [hours] 10.34 (2.19) 9.44 (1.25) 1.79 17 0.09, n.s. 0.42
centroid frequency1 chest vertical [Hz] 1.86 (0.08) 1.90 (0.10) -1.68 17 0.11, n.s. 0.40
time spent walking [hours] 3.55 (1.40) 3.91 (1.42) -1.23 17 0.24, n.s. 0.29
time spent sitting/standing [hours] 10.11 (1.55) 10.65 (1.60) -1.20 17 0.25, n.s. 0.28
centroid frequency1 chest horizontal [Hz] 1.98 (0.06) 1.98 (0.06) -0.12 17 0.91, n.s. 0.03
Abbreviations: SD: standard deviation; n.s. = not significant;
*p0.05;
d: Cohen’s effect size.
1calculated with spectral analysis;
2arbitrary unit: values are based on g but attenuated due to the computation of the spectrum and the nonstationarity of the data;
3cumulative acceleration of the three axes of the chest sensor computed following the rules of vector addition.
doi:10.1371/journal.pone.0124231.t003
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Descriptively we found higher activity in MD-post compared to MD-pre throughout daytime,
but no difference during night time. However, analysis of variance revealed no overall interac-
tion effect [F(23,39) = 1.20, p = 0.242], but significant effects for MD-pre vs. MD-post [F(1,17)
= 5.37, p<0.05] and time [F(23,39) = 36.46, p<0.001].
MD-post spent on average 0.9 (9.44 vs. 10.34; d = 0.42) hours less time per day in a reclined
position than MD-pre. Moreover, MD-post walked on average 0.4 (3.91 vs. 3.55; d = 0.29)
hours more per day than MD-pre. These findings lacked significance (see Table 3). Neverthe-
less, they are in line with our findings comparing MD and HC (see Table 1).
Furthermore, MD-post revealed a more upright posture compared to MD-pre during sitting
and standing, with MD-pre being leaned forward in comparison to MD-post (4 degrees
difference in the vertical body axis). However, this difference is statistically not significant
[t(17) = 1.23, p = 0.235] and effect size is small (d = 0.29).
Discussion
As hypothesised, MD showed lower motor activity measured at the wrist compared to HC (hy-
pothesis I). This result is in line with earlier studies and systematic reviews [3–6,17], enabling
us to perform multiple analyses in order to clarify which sensor placement, analytic strategy
and diurnal time frame best differentiated MD from HC. Looking at single feature-placement
combinations, our data showed that almost all of the calculated feature-placement combina-
tions showed significant differences between MD and HC. This implies that altered motor
activity in depressed patients is not limited to alterations in single extremities, like arm move-
ments, but comprises whole body activity. Mean acceleration measured at the wrist was the
most powerful parameter for distinguishing groups, evidenced by the highest effect size. This is
advantageous, as most previous studies used the wrist for sensor placement [17]. On a theoreti-
cal level, the suitability of wrist placement can be explained by capturing both movement of the
whole body (like walking vs. sleeping) and motor activity of the arms (like arm swings or ges-
tures). In comparison, a device attached to the centre of mass would only be able to capture
movement of the chest or hip. Overall, this is in line with several of our findings, showing
higher effect sizes when the respective parameter contained both core body movement and ac-
tivity of the arms, like arm swing during sitting (pure gesture) vs. arm swing during walking.
Summing up, motor retardation in MD-patients was not only reflected by gross motor activity,
but also in broad domains like gait, gestures and probably fine motor behaviour.
Taking a closer look at the analytic strategies, we used spectral analyses to investigate move-
ment frequencies, providing evidence that both amplitude and frequency were altered in MD
compared to HC. In practice, MD walked less and slower compared to HC. This is in line with
earlier studies showing altered gait patterns, like reduced gait velocity, in depressed subjects
compared to HC [20,31,32]. This finding was confirmed by our analyses on motion patterns
showing that MD spent less time walking and more time lying than HC. Applying logistic re-
gressions, we could also show that the combination of a frequency parameter with wrist accel-
eration differentiated groups best. Therefore, in addition to the mean acceleration of gross
motor activity, which is an expression for the amount of activity, the frequency/speed seems to
be an additional important manifestation of MDD.
Looking at the diurnal variation, differences of motor activity between groups could be de-
scribed during daytime but not night time. In addition, data descriptively did not show distur-
bances in circadian rhythm, as reported in several studies [33], like postponed sleeping phase
[34]. However, our depressed sample consisted of in-patients participating in daily clinical rou-
tines, thereby not being able to choose their own stand-up time, for example.
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Regarding postures, we investigated whether MD and MD-pre were more inclined forward
while sitting and standing throughout the 24 hour period compared to HC and MD-post, re-
spectively, which would be in line with embodiment theories [35] and studies showing relations
between posture and cognitive biases in depression [36]. We found differences in numbers that
did however lack significance. According to the small sample size, we did not differentiate be-
tween subsamples regarding retardation or agitation or regarding treatment success, which
might help distinguish group differences. In addition, fixing the sensor to the head, compared
to the chest, might be better at capturing inclined posture.
Results comparing MD patients at the beginning (MD-pre) vs. after treatment (MD-post)
fit our findings comparing MD vs. HC. Motor activity measured at the wrist after 4 weeks of
treatment was significantly enhanced (hypothesis II), a finding in line with previous research
[5,7–10,17].
In order to clarify the most adequate sensor placement, analytic strategy and diurnal time
frame to distinguish between patients at the beginning and end of treatment we performed
multiple analyses. Similar to the comparison between MD and HC, most of the calculated
feature-placement combinations revealed significant differences between MD-pre and MD-
post. We detected smaller effect sizes in most feature-placement combinations, compared to
MD vs. HC. This was expected as not all of the patients showed enhanced motor activity at the
end of treatment.
Using spectral analysis to analyse movement frequencies showed that only amplitude but
not frequency was enhanced after 4 weeks of in-patient treatment. The finding of enhanced
amplitude of motor activity was supported by heightened walking time next to reduced time
spent in a reclined position. In sum, motor activity in MD-post compared to MD-pre was only
increased with regard to amplitude but not to frequency, implying that patients walked more
but not faster after 4 weeks of in-patient treatment. Whether this was caused by a general lower
walking speed in people prone to depression or by the fact that not all patients in our sample
showed enhanced motor activity at the end of treatment, cannot be determined by our study
and warrants further investigation. Looking at the diurnal variation, differences of motor activ-
ity between groups appeared during daytime but not during night time. However, we did not
find significant differences for specific hours during the day.
In total, our findings lead to two main conclusions: First, using additional sensor-place-
ments and improving analytic strategies is worthwhile for research aiming to examine details
of altered motor activity in depressed subjects. For instance, to differentiate motion patterns
and thereby to discriminate between motor activity of the whole body and motor activity of the
arms, it is crucial to attach sensors to the arm and the trunk. To distinguish amplitude vs. fre-
quency, which can be translated to walking quantity vs. speed, it is necessary to use appropriate
analytic strategies like spectral analysis. Second, we could show that attaching the sensor to the
wrist, as done in most existing studies [17], is most powerful when differentiating between MD
and HC. Measuring acceleration at the wrist seems to be sufficient to indicate general abnor-
malities in motor activity of depressed patients as required in clinical practice, studies examin-
ing treatment success or feedback interventions [37,38] for example.
Some limitations of our study should be mentioned. First, even though our sample size was
relatively small, we could show significant differences, as hypothesised. Group sizes (MD vs.
HC) varied and groups were not matched for age and sex. However, statistical analyses revealed
no significant differences between groups regarding age and sex. In spite of the fact that equally
large and matched groups would have been preferable, medium to high effect sizes enabled us
to perform detailed methodological analyses depicting the best sensor placement, analytic
strategy and diurnal time frame. Second, we used clinical psychiatric examination and chart re-
view to confirm the existence of a depressive episode, which hampers the report of inter-rater
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reliability. Furthermore, the HDRS was assessed by the treating psychiatrists and not by inde-
pendent raters. However, diagnoses were made by experienced psychiatrists and an additional
inclusion criterion was the severity of depression (>18 points on HDRS). Third, patients were
in-patients taking part in daily clinical routine, whereas HC were living at home. Even though
empirical evidence is sparse, clinical routine of patients might led to artificially affected motor
activity, limiting between group differences. However, we found significant differences with
high effect sizes distinguishing both groups and the main focus of the paper was to clarify
methodological issues (sensor placement, analytic strategy, diurnal time). Fourth, motivated by
our methodological focus we used a highly demanding study protocol. Patients wore multiple
sensors, connected by wires, and had to perform a standard protocol at the beginning of the as-
sessment. To limit participant burden, we only monitored two episodes 24 hours in length. For
future studies, which do not focus on methodological issues, we would recommend assessing
longer time frames, including working days and weekend days [19]. Fifth, as the main focus of
our study dealt with methodological issues, we did only include patients suffering fromMDD
and HC. However, abnormalities in motor activity are seen in other psychiatric disorders, too
(e.g. reduced motor activity in residual schizophrenia or enhanced motor activity within manic
episodes of patients suffering from bipolar disorder [1,2]). Therefore, future studies should in-
clude other patient groups to clarify specificity.
In conclusion, our study showed decreased motor activity in patients suffering fromMDD
compared to HC and increased motor activity after treatment compared to the beginning. Fur-
thermore, our findings showed that measuring acceleration at the wrist was sufficient to indi-
cate abnormalities in motor activity of depressed patients. However, application of additional
sensors and more sophisticated analytic strategies are worthwhile to detect more specific differ-
ences of altered motor activity.
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